Compare TENX & TCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TENX | TCI |
|---|---|---|
| Founded | 1967 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.8M | 350.0M |
| IPO Year | 2001 | 1994 |
| Metric | TENX | TCI |
|---|---|---|
| Price | $15.81 | $44.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $29.67 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 3.2K |
| Earning Date | 05-15-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 135.29 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $49,060,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2,167.00 |
| Revenue Growth | N/A | ★ 4.23 |
| 52 Week Low | $5.80 | $31.48 |
| 52 Week High | $19.40 | $59.65 |
| Indicator | TENX | TCI |
|---|---|---|
| Relative Strength Index (RSI) | 56.67 | 52.34 |
| Support Level | $12.84 | $43.15 |
| Resistance Level | $16.35 | $45.56 |
| Average True Range (ATR) | 1.27 | 1.77 |
| MACD | -0.15 | -0.48 |
| Stochastic Oscillator | 41.10 | 15.66 |
Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.
Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates in two business segments: the acquisition, development, ownership and management of multifamily properties; and the acquisition, development, ownership and management of commercial properties; which are office properties. The services for its commercial segment include rental of office space and other tenant services, including parking and storage space rental. The services for its multifamily segment include rental of apartments and other tenant services, including parking and storage space rental. the company derives maximum revenue from Multifamily Segment.